News for BWVI Stock

Historical Regulatory Filing Deficiences Continue to Stifle Psycheceutical Biosciences Psycheceutical Bioscience Strategically Pivots Into the Brain-Computer Interface (BCI) Space Dr. Neilank Jha Appointed as Executive Chairman and Chief Executive Officer of Psycheceutical Bioscience Inc. Psycheceutical Bioscience Launches Wefunder Crowdfunding Campaign for Safer Psychedelic Dosing Psycheceutical Announces Successful First Cohort Dosing; Moves to Dose Escalation in Phase I Trial of NeuroDirect Ketamine for PTSD Psycheceutical Bioscience Announces Completion of PCAOB Audit and Future Corporation Action Strategy First Patient Dosed in Psycheceutical's Phase I Study Exploring Topical Administration of Ketamine to Treat PTSD Psycheceutical Bioscience, Inc. Named a 2023 Top 10 Biotech Startup by Life Sciences Review Psycheceutical Hosts MAPS Founder and Psychedelic Industry Leader Rick Doblin at Its Drug Development Lab Psycheceutical Bioscience, Inc. Announces Observational Research Results for NeuroDirect™ Ketamine Topical Cream in Treating PTSD Psycheceutical to Conduct the First Ever Phase I and II Clinical Trials of a Novel Ketamine Topical Cream to Treat PTSD Psycheceutical Announces Completion of Pre-IND Meeting with FDA for Topical Ketamine Drug to Treat PTSD Psycheceutical Bioscience Provisional Patent Application for Novel Ketamine Topical for the Treatment of PTSD Psycheceutical Announces Julian Bailes, M.D. as Board Member and Chief Medical Officer Dr. Aric Logsdon Joins Psycheceutical Bioscience, Inc. as Company’s Scientific Director Psycheceutical Bioscience, Inc. Announces Medical Advisory Board Psycheceutical Bioscience, Inc.'s Zappy Zapolin Added to The Benzinga Psychedelics Advisory Council Psycheceutical Bioscience, Inc.'s CEO to Present at the Life Sciences Investor Forum on September 15 Psycheceutical Bioscience, Inc. Enters into Exclusive Option to Acquire Vici Health Sciences Psycheceutical Brings on Original Shark from 'Shark Tank,' Kevin Harrington, as Investor and Strategic Advisor Psycheceutical Announces Agreement with Vici Health Sciences Psycheceutical Inc. Announces Initial Corporate Update Psycheceutical Completes Acquisition by Blue Water Ventures International Blue Water Ventures International, Inc. Signs Non-Binding Letter of Intent to Acquire Psycheceutical, Inc. Blue Water Ventures International and Partners Endurance Exploration Group Share Update on the Current 2021 Recovery Season of Steamboat Pulaski New Sonar Survey Discovers Large Unsalvaged Sections of SB Pulaski, 1838 Blue Water Ventures International Signs Extension on Pulaski Recovery